CIK 0001515673
- Large accelerated filer
Ultragenyx Pharmaceutical Inc.
Sign in to watch- Ticker
- RARE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272546083
- Phone
- +1 415-483-8800
- Business address
- 60 LEVERONI COURT, NOVATO, CA, 94949
- 4 Exercise or conversion VP, Controller and PAO acquired 2,448 shares (option exercise)
- 4 Open-market sale Director sold 6,000 shares at $49.69 ($298,140)
- 4 Open-market sale Director sold 6,000 shares at $55.67 ($334,020)
- 4 Exercise or conversion CFO & Executive Vice President acquired 12,000 shares (option exercise)
- 4 Open-market sale Director sold 19,550 shares at an average $72.49 ($1,417,098)
- 3/A Insider 3/A
- 4/A Open-market sale EVP and General Counsel sold 5,000 shares at $78.53 ($392,650)
- 4 Grant or award Chief Operating Officer acquired 15,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale CFO & Executive Vice President sold 6,700 shares at $90.07 ($603,469)
- 4 Open-market sale EVP and General Counsel sold 5,000 shares at $78.53 ($392,650)
- 4 Open-market sale Director sold 3,750 shares at $76.66 ($287,475)
- 4 Shares withheld for taxes Pinion John Richard gave up 649 shares (to pay taxes)
- 4 Open-market sale EVP and General Counsel sold 1,226 shares at $82.77 ($101,476)
- 4 Shares withheld for taxes EVP and General Counsel gave up 649 shares (to pay taxes)
- 4 Grant or award Director acquired 3,000 shares (grant or award)
- 4 Grant or award Director acquired 3,000 shares (grant or award)
- 4 Grant or award Director acquired 3,000 shares (grant or award)
- 4 Grant or award Director acquired 3,000 shares (grant or award)
- 4 Grant or award Director acquired 3,000 shares (grant or award)
Page 20 of 32 · 627 filings